RAMM Pharma Corp. (RAMM.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.06 CAD | 62.47% |
| 2022 | -0.17 CAD | -159.54% |
| 2021 | -0.07 CAD | 11.37% |
| 2020 | -0.07 CAD | 47.21% |
| 2019 | -0.14 CAD | -1958.82% |
| 2018 | -0.01 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.01 CAD | 24.48% |
| 2024 Q1 | -0.02 CAD | 40.56% |
| 2024 Q3 | -0.01 CAD | 42.76% |
| 2023 FY | - CAD | 62.47% |
| 2023 Q2 | -0.01 CAD | 30.71% |
| 2023 Q4 | -0.03 CAD | -275.58% |
| 2023 Q1 | -0.01 CAD | 89.23% |
| 2023 Q3 | -0.01 CAD | 11.34% |
| 2022 Q3 | -0.01 CAD | -7.06% |
| 2022 Q2 | -0.01 CAD | 45.51% |
| 2022 Q1 | -0.02 CAD | 8.77% |
| 2022 FY | - CAD | -159.54% |
| 2022 Q4 | -0.13 CAD | -1328.57% |
| 2021 Q1 | -0.01 CAD | 38.4% |
| 2021 FY | - CAD | 11.37% |
| 2021 Q4 | -0.02 CAD | 43.38% |
| 2021 Q3 | -0.03 CAD | -602.33% |
| 2021 Q2 | -0.00 CAD | 70.55% |
| 2020 Q4 | -0.02 CAD | -34.66% |
| 2020 FY | - CAD | 47.21% |
| 2020 Q3 | -0.02 CAD | -41.94% |
| 2020 Q2 | -0.01 CAD | 38.92% |
| 2020 Q1 | -0.02 CAD | 57.44% |
| 2019 Q1 | -0.00 CAD | 0.0% |
| 2019 Q3 | -0.01 CAD | 44.95% |
| 2019 Q2 | -0.01 CAD | -263.33% |
| 2019 Q4 | -0.05 CAD | -695.0% |
| 2019 FY | - CAD | -1958.82% |
| 2018 FY | - CAD | 0.0% |